These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1752960)

  • 1. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin.
    Lantz M; Thysell H; Nilsson E; Olsson I
    J Clin Invest; 1991 Dec; 88(6):2026-31. PubMed ID: 1752960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
    Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infusion of tumor necrosis factor (TNF) causes an increase in circulating TNF-binding protein in humans.
    Lantz M; Malik S; Slevin ML; Olsson I
    Cytokine; 1990 Nov; 2(6):402-6. PubMed ID: 2129506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms involved in the processing of the p55 and the p75 tumor necrosis factor (TNF) receptors to soluble receptor forms.
    Björnberg F; Lantz M; Olsson I; Gullberg U
    Lymphokine Cytokine Res; 1994 Jun; 13(3):203-11. PubMed ID: 7948429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective release of tumor necrosis factor binding protein II by malignant human epidermal cells reveals protection from tumor necrosis factor alpha-mediated cytotoxicity.
    Neuner P; Klosner G; Pourmojib M; Trautinger F; Knobler R
    Cancer Res; 1994 Nov; 54(22):6001-5. PubMed ID: 7954434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and expression of human and rat tumor necrosis factor receptor chain (p60) and its soluble derivative, tumor necrosis factor-binding protein.
    Himmler A; Maurer-Fogy I; Krönke M; Scheurich P; Pfizenmaier K; Lantz M; Olsson I; Hauptmann R; Stratowa C; Adolf GR
    DNA Cell Biol; 1990 Dec; 9(10):705-15. PubMed ID: 1702293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody-based enzyme immunoassay for quantitation of human tumor necrosis factor binding protein I, a soluble fragment of the 60 kDa TNF receptor, in biological fluids.
    Adolf GR; Apfler I
    J Immunol Methods; 1991 Sep; 143(1):127-36. PubMed ID: 1919033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tumor necrosis factor binding protein (TNF-BP)-physiological antagonist of TNF.
    Olsson I; Gullberg U; Lantz M; Peetre C
    Biotherapy; 1991; 3(2):159-65. PubMed ID: 2054256
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.
    Lantz M; Gullberg U; Nilsson E; Olsson I
    J Clin Invest; 1990 Nov; 86(5):1396-1402. PubMed ID: 2173717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the effects of tumor necrosis factor inhibitors on human hematopoiesis.
    Ferrajoli A; Talpaz M; Kurzrock R; Estrov Z
    Stem Cells; 1993 Mar; 11(2):112-9. PubMed ID: 8384506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-induced superoxide anion production in adherent human neutrophils involves both the p55 and p75 TNF receptor.
    Richter J; Gullberg U; Lantz M
    J Immunol; 1995 Apr; 154(8):4142-9. PubMed ID: 7706751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor is delivered to mitochondria where a tumor necrosis factor-binding protein is localized.
    Ledgerwood EC; Prins JB; Bright NA; Johnson DR; Wolfreys K; Pober JS; O'Rahilly S; Bradley JR
    Lab Invest; 1998 Dec; 78(12):1583-9. PubMed ID: 9881958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Glomerular expression of tumor necrosis factor alpha (TNF-alpha) and of its receptors].
    Baud L; Fouqueray B; Philippe C
    C R Seances Soc Biol Fil; 1993; 187(4):434-9. PubMed ID: 8019919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor (TNF alpha) binding protein: interference in immunoassays of TNF alpha.
    Haran N; Bar-Khayim Y; Frensdorff A; Barnard G
    Kidney Int; 1991 Dec; 40(6):1166-70. PubMed ID: 1762319
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumour necrosis factor (TNF) binding proteins (soluble TNF receptor forms) with possible roles in inflammation and malignancy.
    Olsson I; Gatanaga T; Gullberg U; Lantz M; Granger GA
    Eur Cytokine Netw; 1993; 4(3):169-80. PubMed ID: 8218941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
    Galve-de Rochemonteix B; Nicod LP; Dayer JM
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified antisense oligonucleotides directed against tumor necrosis factor receptor type I inhibit tumor necrosis factor alpha-mediated functions.
    Ojwang JO; Mustain SD; Marshall HB; Rao TS; Chaudhary N; Walker DA; Hogan ME; Akiyama T; Revankar GR; Peyman A; Uhlmann E; Rando RF
    Biochemistry; 1997 May; 36(20):6033-45. PubMed ID: 9166774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: renal tubular vacuolation in animals treated with polyethylene-glycol-conjugated proteins.
    Bendele A; Seely J; Richey C; Sennello G; Shopp G
    Toxicol Sci; 1998 Apr; 42(2):152-7. PubMed ID: 9579027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble TNF binding proteins modulate the negative inotropic properties of TNF-alpha in vitro.
    Kapadia S; Torre-Amione G; Yokoyama T; Mann DL
    Am J Physiol; 1995 Feb; 268(2 Pt 2):H517-25. PubMed ID: 7864177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endotoxemic renal failure in mice: Role of tumor necrosis factor independent of inducible nitric oxide synthase.
    Knotek M; Rogachev B; Wang W; Ecder T; Melnikov V; Gengaro PE; Esson M; Edelstein CL; Dinarello CA; Schrier RW
    Kidney Int; 2001 Jun; 59(6):2243-9. PubMed ID: 11380827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.